RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
Linking cigarette smoke and obesity: What our genes and environmental factors tell us

Oct 3, 2007 - 4:00:00 AM
Plasma samples for the study will be obtained from 500 individuals participating in a study being conducted by the University of Utah. That study includes non-smokers, smokers, smokers with chronic obstructive pulmonary disease, and people exposed to second-hand smoke. Researchers at the W.R. Wiley Environmental Molecular Sciences Laboratory located at PNNL will identify the peptides from these samples using state-of-the art tandem mass spectrometry.

 
[RxPG] RICHLAND, Wash. � Identifying biomarkers for the key environmental risk factors responsible for two diseases that significantly contribute to death and disease of hundreds of thousands annually will be the initial focus of a new center being established at Pacific Northwest National Laboratory. PNNL will house the Center for Novel Biomarkers of Response, made possible by a $5.9 million grant recently awarded by the National Institutes of Health�s Gene and Environment Initiative.

Scientists at the center intend to create new exposure assessment tools to better understand the role of gene-environmental interactions in human disease. Development of these tools will help scientists precisely measure personal exposure to environmental, chemical and biological agents.

�While the Human Genome Project has enabled faster, cheaper gene sequencing of individuals,� said PNNL Center Director and toxicologist Joel Pounds, �genes alone don�t tell the whole story. The environment plays an enormous role in complex disease development including cancers, asthma, diabetes and neurodegerative diseases.�

�We can identify genetic variability and the genetic factors in an individual person, but it is much more difficult to define an individual�s environment and chemicals he or she is exposed to,� said Pounds. �Our challenge will be to understand how genes and the environment interact. To do that, we have to improve the ability to measure environmental factors at the individual level.�

Two of the most important risk factors for human morbidity and mortality � cigarette smoke and obesity � will be the primary targets of interest for PNNL scientists. Research will focus on biomarkers for systemic stress caused by mainstream and second-hand cigarette smoke, with obesity as a confounding physiological factor. PNNL will team with researchers from the University of Utah and Battelle Toxicology Northwest in conducting this research.

This research, in support of the NIH Gene and Environmental Initiative, is comprised of two basic elements. The genetic component will rely on newfound abilities to swiftly identify genetic differences between people with illnesses and those who are healthy, leading to a greater understanding of genetic contribution to the disease. The environmental biology component will focus on developing new technologies to accurately measure personal exposures with small, wearable sensors that can be used to assess environmental agents.

The center will provide NIH�s National Institute of Environmental Health Sciences with a database of response biomarkers, as well as chemical substances for selected markers that are tested and validated in humans and supported by parallel studies in mice. The researchers will also develop prototype nanotechnology-based sensors for measurement of biomarkers at the point of care.

Plasma samples for the study will be obtained from 500 individuals participating in a study being conducted by the University of Utah. That study includes non-smokers, smokers, smokers with chronic obstructive pulmonary disease, and people exposed to second-hand smoke. Researchers at the W.R. Wiley Environmental Molecular Sciences Laboratory located at PNNL will identify the peptides from these samples using state-of-the art tandem mass spectrometry.

Over the course of the four-year project, scientists will work closely with PNNL�s Environmental Biomarkers Initiative. The EBI is an internally funded program, which has provided the scientific foundation and initial laboratory tools for the NIH center.




Advertise in this space for $10 per month. Contact us today.


Related Latest Research News


Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)